297 related articles for article (PubMed ID: 23201239)
21. Safe use of liver grafts from hepatitis B surface antigen positive donors in liver transplantation.
Yu S; Yu J; Zhang W; Cheng L; Ye Y; Geng L; Yu Z; Yan S; Wu L; Wang W; Zheng S
J Hepatol; 2014 Oct; 61(4):809-15. PubMed ID: 24824283
[TBL] [Abstract][Full Text] [Related]
22. Prevention of hepatitis B virus infection from hepatitis B core antibody-positive donor graft using hepatitis B immune globulin and lamivudine in living donor liver transplantation.
Suehiro T; Shimada M; Kishikawa K; Shimura T; Soejima Y; Yoshizumi T; Hashimoto K; Mochida Y; Maehara Y; Kuwano H
Liver Int; 2005 Dec; 25(6):1169-74. PubMed ID: 16343068
[TBL] [Abstract][Full Text] [Related]
23. Use of hepatitis B core antibody-positive liver allograft in hepatitis C virus-positive and -negative recipients with use of short course of hepatitis B immunoglobulin and Lamivudine.
Jain A; Orloff M; Abt P; Kashyap R; Mohanka R; Lansing K; Kelley M; Bozorgzadeh A
Transplant Proc; 2005 Sep; 37(7):3187-9. PubMed ID: 16213345
[TBL] [Abstract][Full Text] [Related]
24. The risks of HBV infection after liver transplantation from HBc antibody positive donor to HBs antibody positive recipient.
Ikegami T; Taketomi A; Ohta R; Soejima Y; Yoshizumi T; Harada N; Shimada M; Maehara Y
Hepatogastroenterology; 2008; 55(88):2162-5. PubMed ID: 19260497
[TBL] [Abstract][Full Text] [Related]
25. Pre-transplant donor HBV DNA+ and male recipient are independent risk factors for treatment failure in HBsAg+ donors to HBsAg- kidney transplant recipients.
Wang XD; Feng SJ; Liu JP; Song TR; Huang ZL; Fan Y; Shi YY; Chen LY; Lv YH; Xu ZL; Li XH; Wang L; Lin T
BMC Infect Dis; 2021 Jan; 21(1):41. PubMed ID: 33422017
[TBL] [Abstract][Full Text] [Related]
26. Survival after orthotopic liver transplantation: the impact of antibody against hepatitis B core antigen in the donor.
Yu L; Koepsell T; Manhart L; Ioannou G
Liver Transpl; 2009 Oct; 15(10):1343-50. PubMed ID: 19790164
[TBL] [Abstract][Full Text] [Related]
27. Donor pool expansion in liver transplantation.
Montalti R; Nardo B; Bertelli R; Beltempo P; Puviani L; Vivarelli M; Cavallari A
Transplant Proc; 2004 Apr; 36(3):520-2. PubMed ID: 15110578
[TBL] [Abstract][Full Text] [Related]
28. Impact of hepatitis B core antibody positive donors in lung and heart-lung transplantation: an analysis of the United Network For Organ Sharing Database.
Dhillon GS; Levitt J; Mallidi H; Valentine VG; Gupta MR; Sista R; Weill D
Transplantation; 2009 Sep; 88(6):842-6. PubMed ID: 19920785
[TBL] [Abstract][Full Text] [Related]
29. The risk of transmission of hepatitis B from HBsAg(-), HBcAb(+), HBIgM(-) organ donors.
Wachs ME; Amend WJ; Ascher NL; Bretan PN; Emond J; Lake JR; Melzer JS; Roberts JP; Tomlanovich SJ; Vincenti F
Transplantation; 1995 Jan; 59(2):230-4. PubMed ID: 7839446
[TBL] [Abstract][Full Text] [Related]
30. Liver transplantation from hepatitis B surface antigen positive donors: a safe way to expand the donor pool.
Loggi E; Micco L; Ercolani G; Cucchetti A; Bihl FK; Grazi GL; Gitto S; Bontadini A; Bernardi M; Grossi P; Costa AN; Pinna AD; Brander C; Andreone P
J Hepatol; 2012 Mar; 56(3):579-85. PubMed ID: 22027583
[TBL] [Abstract][Full Text] [Related]
31. Use of renal allografts from donors positive for hepatitis B core antibody confers minimal risk for subsequent development of clinical hepatitis B virus disease.
Madayag RM; Johnson LB; Bartlett ST; Schweitzer EJ; Constantine NT; McCarter RJ; Kuo PC; Keay S; Oldach DW
Transplantation; 1997 Dec; 64(12):1781-6. PubMed ID: 9422420
[TBL] [Abstract][Full Text] [Related]
32. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection.
Su WJ; Ho MC; Ni YH; Chen HL; Hu RH; Wu YM; Chang MH; Lee PH
J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):203-8. PubMed ID: 19179883
[TBL] [Abstract][Full Text] [Related]
33. Use of liver grafts from donors positive for antihepatitis B-core antibody (anti-HBc) in the era of prophylaxis with hepatitis-B immunoglobulin and lamivudine.
Nery JR; Nery-Avila C; Reddy KR; Cirocco R; Weppler D; Levi DM; Nishida S; Madariaga J; Kato T; Ruiz P; Schiff E; Tzakis AG
Transplantation; 2003 Apr; 75(8):1179-86. PubMed ID: 12717200
[TBL] [Abstract][Full Text] [Related]
34. Successful active immunization using a hepatitis B virus vaccination protocol for a recipient with hepatitis B core antibody-positive liver graft.
Ohno Y; Mita A; Ikegami T; Masuda Y; Urata K; Nakazawa Y; Kobayashi A; Miyagawa S
Transplant Proc; 2014 Apr; 46(3):721-5. PubMed ID: 24767333
[TBL] [Abstract][Full Text] [Related]
35. Hepatitis B prophylaxis in hepatitis B-negative recipients transplanted with donor grafts positive for hepatitis B core antibodies.
Scuderi V; Ceriello A; Santaniello W; Aragiusto G; Romano M; Migliaccio C; Calise F
Transplant Proc; 2011; 43(1):271-3. PubMed ID: 21335203
[TBL] [Abstract][Full Text] [Related]
36. Expanding the donor pool: Kidney transplantation from serum HBV DNA or HBeAg-positive donors to HBsAg-negative recipients.
Yin S; Wu L; Zhang F; Huang X; Wu J; Wang X; Lin T
Liver Int; 2023 Nov; 43(11):2415-2424. PubMed ID: 37592870
[TBL] [Abstract][Full Text] [Related]
37. Transplanting kidneys from donors with prior hepatitis B infection: one response to the organ shortage.
Fabrizio F; Bunnapradist S; Martin P
J Nephrol; 2002; 15(6):605-13. PubMed ID: 12495272
[TBL] [Abstract][Full Text] [Related]
38. De novo hepatitis b prophylaxis with hepatitis B virus vaccine and hepatitis B immunoglobulin in pediatric recipients of core antibody-positive livers.
Lee S; Kim JM; Choi GS; Park JB; Kwon CH; Choe YH; Joh JW; Lee SK
Liver Transpl; 2016 Feb; 22(2):247-51. PubMed ID: 26600319
[TBL] [Abstract][Full Text] [Related]
39. Hepatitis B virus reactivation and efficacy of prophylaxis with lamivudine in patients undergoing allogeneic stem cell transplantation.
Giaccone L; Festuccia M; Marengo A; Resta I; Sorasio R; Pittaluga F; Fiore F; Boccadoro M; Rizzetto M; Bruno B; Marzano A
Biol Blood Marrow Transplant; 2010 Jun; 16(6):809-17. PubMed ID: 20060484
[TBL] [Abstract][Full Text] [Related]
40. [A study of the efficacy and safety of using hepatitis B surface antigen-positive donors for liver transplantation].
Ju WQ; He XS; Wang DP; Deng RH; Wu LW; Guo ZY; Zhu XF; Huang JF
Zhonghua Gan Zang Bing Za Zhi; 2012 Jan; 20(1):14-6. PubMed ID: 22464699
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]